DEA Regulatory Compliance

DEA registrants play a vital role in preventing diversion of controlled substances, protecting the closed system of distribution, and maintaining the integrity of the controlled substances supply chain. Now, more than ever, all DEA registrants  must be proactive and effective in their internal assessments of anything and everything related to controlled substances as well as with their external engagements with government regulators.

Our DEA Regulatory Compliance practice is made up of nationally respected, multi-disciplinary experts in the Controlled Substances Act (CSA) and the Code of Federal Regulations (CFR). The team includes former DEA attorneys and compliance experts, Diversion Investigators, and Special Agents. Our experts can outline the appropriate steps to ensure compliance with the regulatory requirements of a DEA registration and help avoid the financial and reputational risk that can result from noncompliance, including potential enforcement actions.  We have successfully worked with our clients to establish compliance programs that have withstood the scrutiny of DEA.

In both the public and private sector, our experience has been that the majority of DEA registrants are law-abiding and have appropriate anti-diversion protocols in place. However, there are times when a discrepancy occurs between delineated protocols and actual implementation. That is why we recommend a periodic review and assessment of any anti-diversion program, including its policies and procedures and personnel training practices. This can serve to enhance an already robust compliance program. Further, proactive and effective external engagement with government regulators and investigators is also critical to improve communication, receive clarity regarding nuanced regulatory requirements, and minimize litigation risk associated with government investigations.

We can assist you in navigating the regulatory “waters” in any number of ways.  The variety of services we offer can be tailored to meet your specific needs.

Contact Us

Services

Anti-Diversion Compliance Program

  • We will conduct a full assessment of your DEA regulatory compliance program to ensure compliance with the CSA and CFR.
  • If you do not have an anti-diversion compliance program, we will work with you to create one customized for your business needs.
  • Our assessments will include an evaluation of controlled substance policies and procedures, anti-diversion and due diligence measures and systems, training protocols, personnel hiring and support, and effective compliance controls.
  • We can include suggestions for overall enhancements and program improvement, assist with implementation, and provide program and monitoring support.

Preparing for a DEA Inspection

  • We work with you and your team to ensure you are fully prepared for a DEA inspection.
  • We will conduct a mock DEA inspection, consisting of an on-site review of policies and procedures and controlled substance records, the creation/review of DEA binders, completing an accountability audit, assessing effective controls, and conducting employee interviews.
  • We will provide trainings related to controlled substances compliance and what to expect from DEA.

DEA Registrant Assistance – New and Existing Registrants

  • We will review all aspects of your DEA registration(s) to ensure compliance and provide recommendations as appropriate.
  • We will collaborate with you to ensure understanding of the regulations and requirements.
  • We will assist with the creation of policies and procedures, and compilation and review of DEA binders for each registration.
  • For new DEA registrants, we offer application assistance, creation of policies and procedures, compilation of DEA binders, preparation for DEA pre-registration inspection, including mock inspection.

Full Complement of DEA Regulatory Compliance Trainings

  • Soon-to-be CME accredited
  • Can be customized to meet the needs of your business
  • Can be live, virtual, or a combination
  • “Train-the-trainer” options available

Case Studies

Media + Events

a person is typing on a laptop with three page icons on top of it
March 27, 2024

Navigating the DEA Registration Application Process

Continue Reading
September 14, 2017

DEA Registrants Play a Vital Role in Preventing Diversion

Continue Reading
unfocused picture of people walking through a professional event
March 11, 2024

NADDI Mississippi Chapter Conference

NADDI Mississippi Chapter Conference

Continue Reading
a blurry picture of a convention with a blue floor
March 5, 2024

NADDI Maryland Chapter Conference

NADDI Maryland Chapter Conference

Continue Reading
a coffee cup sits on a saucer in front of a group of people
January 22, 2024

NADDI 2023 34th Annual Conference

NADDI 2023 34th Annual Conference

Continue Reading
an open magazine
April 5, 2023

bloomberg.com

Xanax and Adderall Access Is Being Blocked by Secret Drug Limits

Continue Reading
a stack of folded newspapers
February 2, 2023

Wall Street Journal

Sour U.S.-China Relations Feed the Fentanyl Crisis

Continue Reading
a close up of a microphone in front of a laptop
May 31, 2023

How Prepared is Your Facility for a Visit from the DEA?

Listen to Podcast
a close up of a microphone with a sound wave behind it
February 1, 2021

Guidepost in Motion: Red Flags of Drug Diversion Episode 2

Listen to Podcast
a close up of a microphone with a sound wave behind it
February 1, 2021

Guidepost in Motion: Red Flags of Drug Diversion Episode 2

Listen to Podcast
a close up of a microphone in front of a laptop
January 21, 2021

Guidepost in Motion: Red Flags of Drug Diversion Episode 1

Listen to Podcast
a close up of a microphone with a sound wave behind it
January 21, 2021

Guidepost in Motion: Red Flags of Drug Diversion Episode 1

Listen to Podcast
a woman stands at a podium with a microphone in front of her
September 19, 2023

Guidepost Solutions Grows Leadership Team with the Rehire of Louis J. Milione

Continue Reading
a person is holding a cell phone with the news app open
February 28, 2023

Guidepost Solutions Expands DEA Regulatory Compliance Practice

Continue Reading
a stack of folded newspapers
August 2, 2021

Guidepost Solutions Welcomes Russell Holske, Drug Enforcement Administration Leader and Pharmaceutical Investigations Chief

Continue Reading
InvestigationHotlines